                         SEQUENCE LISTING

<110>  INSERM
       LABARRIERE, Nathalie
 
<120>  NOVEL MELANOMA ANTIGEN PEPTIDE AND USES THEREOF

<130>  BEP080461

<160>  42    

<170>  PatentIn version 3.3

<210>  1
<211>  2154
<212>  DNA
<213>  homo sapiens

<400>  1
atccccaccc acccggctcc caggatcctc attaggaagc cctcaggagc cctggggtgg     60

gtctccttgc cctgtgaacg ctccatttgt gttattgaat ccaacataaa tgcagcattg    120

tcttcagagg tgagcaatgg ccgtggccgg aggtgcgcat gggatgcagg cggcgtgtgc    180

tgctgttgat tttctctgct ctgctcttag cttactttag cagatagtgg agtttcacgt    240

ggcagtccgg taaaccaagg cagtgtgaac atcccttccc cacaatgagt gaaaatgcag    300

gaggtgccgt agcgagaaca gcgacagcat tctgcgcatt ggtgagcccg actccccagc    360

ctcggtgccc accgaagccc cctctggctg cactgtgcca gtgagtccag gctccttctc    420

agcagaaggt ggctgctctg cagggcccct cgcctccctg ctcctcaggg gacccgcact    480

cttccatgtc cgtagggaga cgcgcaccga gctggagaca cagatctgcg aggagtaact    540

tgcctctctc accagcactg ccaggggcgg atcagcgcca gcaccttcca gcatgcgcta    600

aactgctgga gaagctggag tggctggaag gagccctgcc tgcctgccct cctcctcctc    660

agttgctggc cttggcagct ctagggtgac ccagcagggg cctggaggag taggaagcag    720

cttcccagct gcagtctgca tcatcctctc tgtgctgtca cagaatggaa ggttttagca    780

gaaaaaggag tttgtaagcg acattcagaa gatttgggca gcagtttctt cccccatagg    840

gtcctgtctt ttgggagtgg ggagtgctgg gccaggctgc tcgctggctg tttcacaggt    900

ggtggaattt aagagcagac ttgggtcgag ctgtgaccgt tcaggtgatg cacgcacagg    960

aggttcagct gtgtgcctgt gaggcaggca ggagcgtcac ccaagcttca gaagagaatt   1020

ccccggcagc agcgtggcgc tcagcatgtt ccgtgtctga ctgttttgat tgtctctcag   1080

tccagttgac aaattccttt taagatgaaa tttgaattaa tttgcagaac ttgtacaaat   1140

ctccaagaaa acagcttaag gaacagatta aagaatgaat gccttaggaa ttaaagcatt   1200

aatagctctt gagtagactg gatggaaaga tgagttgtgt aggttatcca gatgaggcta   1260

catccaggga gcaattctta ccttcagagg gcgctgcctg tcctccttgg catccaagtg   1320

agcgcatctc ctccacgctc aatgatgaat gctggccggc atccctgtga ggaaccttgt   1380

gatcattttc catttctgaa aactcccagg tggtgggggc ccttggccca catcagcatt   1440

gaccaccccg ggctcagatc tggccaggtg cctgcgttgt gatgggaatt tcagtacact   1500

gaattttgcc tctgaccctg atgaaatagc ttcggtggca tttgcatcaa gatcatgtta   1560

gtgtcatctc tattagatgc tttggagcaa acatgaactt gggtttcctt ttaagatgtc   1620

ctgtgattcc agattcaggg gaatctgaga aaagtttgaa gaaagaaaat tccactcggc   1680

cagccaacct tgggtgtgca gagcctgccc cgccttcccc actttgtcct gagaagctgg   1740

gtcctcccca gcaccagagt tgctgctgct tcccctcgcg ctcttggctg ctctcccggc   1800

cccaagcctg agtgacactc taggattgca gatggcaggc tggtctctgg gctcccccgt   1860

ccccatgacc ctccacctgc acccagacct ctgggtcctt gctcaggcag cccctgccct   1920

cggtgagacg cagcccactg tgggcccttc ccctgggcct gccatcagct cctgtgctcc   1980

tcggcgcccc agcggctgcc ctgggcccgt tcccacagca cctggcacac agcaggagcc   2040

atgaatgttc tttgggaact gaatgaggag tggaaatgcg ggcatgtcat gtttttgaag   2100

ttaataaaaa aaatccctta aaagttgaaa aaaaaaaaaa aaaaaaaaaa aaaa         2154


<210>  2
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 1


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is L, M, V, I or Q

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is A, V or L

<400>  2

Thr Xaa Asn Asp Glu Cys Trp Pro Xaa 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is C, L, M, V, I or Q

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is A, V or L

<400>  3

Arg Xaa Pro Pro Lys Pro Pro Leu Xaa 
1               5                   


<210>  4
<211>  46
<212>  PRT
<213>  artificial

<220>
<223>  MELOE-1

<400>  4

Met Ser Cys Val Gly Tyr Pro Asp Glu Ala Thr Ser Arg Glu Gln Phe 
1               5                   10                  15      


Leu Pro Ser Glu Gly Ala Ala Cys Pro Pro Trp His Pro Ser Glu Arg 
            20                  25                  30          


Ile Ser Ser Thr Leu Asn Asp Glu Cys Trp Pro Ala Ser Leu 
        35                  40                  45      


<210>  5
<211>  39
<212>  PRT
<213>  artificial

<220>
<223>  MELOE-2

<400>  5

Met Ser Glu Asn Ala Gly Gly Ala Val Ala Arg Thr Ala Thr Ala Phe 
1               5                   10                  15      


Cys Ala Leu Val Ser Pro Thr Pro Gln Pro Arg Cys Pro Pro Lys Pro 
            20                  25                  30          


Pro Leu Ala Ala Leu Cys Gln 
        35                  


<210>  6
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 1

<400>  6

Thr Leu Asn Asp Glu Cys Trp Pro Ala 
1               5                   


<210>  7
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 1

<400>  7

Thr Met Asn Asp Glu Cys Trp Pro Ala 
1               5                   


<210>  8
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 1

<400>  8

Thr Val Asn Asp Glu Cys Trp Pro Ala 
1               5                   


<210>  9
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 1

<400>  9

Thr Ile Asn Asp Glu Cys Trp Pro Ala 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 1

<400>  10

Thr Gln Asn Asp Glu Cys Trp Pro Ala 
1               5                   


<210>  11
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 1

<400>  11

Thr Leu Asn Asp Glu Cys Trp Pro Val 
1               5                   


<210>  12
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 1

<400>  12

Thr Met Asn Asp Glu Cys Trp Pro Val 
1               5                   


<210>  13
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 1

<400>  13

Thr Val Asn Asp Glu Cys Trp Pro Val 
1               5                   


<210>  14
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 1

<400>  14

Thr Ile Asn Asp Glu Cys Trp Pro Val 
1               5                   


<210>  15
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 1

<400>  15

Thr Gln Asn Asp Glu Cys Trp Pro Val 
1               5                   


<210>  16
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 1

<400>  16

Thr Leu Asn Asp Glu Cys Trp Pro Leu 
1               5                   


<210>  17
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 1

<400>  17

Thr Met Asn Asp Glu Cys Trp Pro Leu 
1               5                   


<210>  18
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 1

<400>  18

Thr Val Asn Asp Glu Cys Trp Pro Leu 
1               5                   


<210>  19
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 1

<400>  19

Thr Ile Asn Asp Glu Cys Trp Pro Leu 
1               5                   


<210>  20
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 1

<400>  20

Thr Gln Asn Asp Glu Cys Trp Pro Leu 
1               5                   


<210>  21
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  21

Arg Cys Pro Pro Lys Pro Pro Leu Ala 
1               5                   


<210>  22
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  22

Arg Leu Pro Pro Lys Pro Pro Leu Ala 
1               5                   


<210>  23
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  23

Arg Met Pro Pro Lys Pro Pro Leu Ala 
1               5                   


<210>  24
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  24

Arg Val Pro Pro Lys Pro Pro Leu Ala 
1               5                   


<210>  25
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  25

Arg Ile Pro Pro Lys Pro Pro Leu Ala 
1               5                   


<210>  26
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  26

Arg Gln Pro Pro Lys Pro Pro Leu Ala 
1               5                   


<210>  27
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  27

Arg Cys Pro Pro Lys Pro Pro Leu Val 
1               5                   


<210>  28
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  28

Arg Leu Pro Pro Lys Pro Pro Leu Val 
1               5                   


<210>  29
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  29

Arg Met Pro Pro Lys Pro Pro Leu Val 
1               5                   


<210>  30
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  30

Arg Val Pro Pro Lys Pro Pro Leu Val 
1               5                   


<210>  31
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  31

Arg Ile Pro Pro Lys Pro Pro Leu Val 
1               5                   


<210>  32
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  32

Arg Gln Pro Pro Lys Pro Pro Leu Val 
1               5                   


<210>  33
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  33

Arg Cys Pro Pro Lys Pro Pro Leu Leu 
1               5                   


<210>  34
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  34

Arg Leu Pro Pro Lys Pro Pro Leu Leu 
1               5                   


<210>  35
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  35

Arg Met Pro Pro Lys Pro Pro Leu Leu 
1               5                   


<210>  36
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  36

Arg Val Pro Pro Lys Pro Pro Leu Leu 
1               5                   


<210>  37
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  37

Arg Ile Pro Pro Lys Pro Pro Leu Leu 
1               5                   


<210>  38
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  melanoma antigen peptide 2

<400>  38

Arg Gln Pro Pro Lys Pro Pro Leu Leu 
1               5                   


<210>  39
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  MART-1 peptide

<400>  39

Ala Ala Gly Ile Gly Ile Leu Thr Val 
1               5                   


<210>  40
<211>  10
<212>  PRT
<213>  artificial

<220>
<223>  MART-1 peptide

<400>  40

Glu Ala Ala Gly Ile Gly Ile Leu Thr Val 
1               5                   10  


<210>  41
<211>  10
<212>  PRT
<213>  artificial

<220>
<223>  MART-1 peptide

<400>  41

Ala Ala Gly Ile Gly Ile Leu Thr Val Ile 
1               5                   10  


<210>  42
<211>  10
<212>  PRT
<213>  artificial

<220>
<223>  MART-1 peptide

<400>  42

Glu Leu Ala Gly Ile Gly Ile Leu Thr Val 
1               5                   10  


